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K-Ras cell transformationMetabolic adaptations are associated with changes in enzyme activities. These adaptations are characterized
by patterns of positive and negative changes in metabolic ﬂuxes and concentrations of intermediate
metabolites. Knowledge of the mechanism and parameters governing enzyme kinetics is rarely available.
However, the signs—increases or decreases—of many of these changes can be predicted using the signs of
metabolic control coefﬁcients. These signs require the only knowledge of the structure of the metabolic
network and a limited qualitative knowledge of the regulatory dependences, which is widely available for
carbon metabolism. Here, as a case study, we identiﬁed control coefﬁcients with ﬁxed signs in order to
predict the pattern of changes in key enzyme activities which can explain the observed changes in ﬂuxes
and concentrations underlying the metabolic adaptations in oncogenic K-ras transformation in NIH-3T3
cells. The ﬁxed signs of control coefﬁcients indicate that metabolic changes following the oncogenic
transformation—increased glycolysis and oxidative branch of the pentose-phosphate pathway, and decreased
concentration in sugar-phosphates—could be associated with increases in activity for glucose-6-phosphate
dehydrogenase, pyruvate kinase and lactate dehydrogenase, and decrease for transketolase. These predictions
were validated experimentally by measuring speciﬁc activities. We conclude that predictions based on ﬁxed
signs of control coefﬁcients are a very robust tool for the identiﬁcation of changes in enzyme activities that can
explain observed metabolic adaptations in carbon metabolism. This article is part of a Special Issue entitled:
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Metabolic concentrations and ﬂuxes are the constrained
components characterizing the collective action of cell metabolism,which are modulated by enzymatic activities. However, we have
partial knowledge of the components of cell metabolism and the
constraints relating them. Specially, we have limited knowledge
of the kinetic properties of the enzymes and their regulation.
Moreover, the observed heterogeneity in cell populations,
associated with phenomena like protein crowding, interactions
between glycolytic enzymes, and reversible associations with
structural proteins or organelles [1,2] should alter both compo-
nents and constraints. These limitations are likely to make
systems in part unpredictable, speciﬁcally the magnitude of the
changes following alterations in the activity of enzymes. Interest-
ingly, the predicted sign of changes in metabolite concentrations
andmetabolic ﬂuxes following changes in enzyme activity is likely to be
more robust and allows their prediction without requiring accurate
kinetic information. Metabolic control analysis (MCA) [3–5] is one
framework which permits the prediction of the signs of concentration
and ﬂux changes.
In the framework of MCA, systemic properties of the whole
network are described as a function of the properties of enzymes
isolated from the system. Steady state ﬂuxes and metabolite
concentrations are systemic properties. Enzyme rates, by contrast,
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mechanism and parameters governing the enzyme kinetics. Under
MCA, an elasticity εqk is the parameter sensitivity of the rate vq of an
isolated reaction—at steady state conditions—with respect to changes
in the concentration xk of one of its substrate, inhibitor or any other
kinetic effectors of the isolated reaction [3,4]:
εqk =
∂ ln vq
∂ ln xk
ð1Þ
Similarly, a control coefﬁcient is a system property deﬁned as the
sensitivity of a metabolite concentration xg or a ﬂux Jq with respect to
changes in some parameter p—usually the enzyme concentration—
whichwill in principle be proportional to the rate vkwhen the enzyme
is isolated, and then associated to the enzyme activity [3,4]:
Cgk =
∂ ln xg
∂ln p
,
∂ ln vk
∂ ln p =
∂ ln xg
∂ ln vk
ð2Þ
Cqk =
∂ ln Jq
∂ ln p
,
∂ ln vk
∂ ln p =
∂ ln Jq
∂ ln vk
ð3Þ
Different approaches have been proposed for describing the
control coefﬁcients, including methods based on matrices [6–10]
and those based on graph theoretical procedures [11,12]. These
methods allow the derivation of large expressions describing the
control coefﬁcients, whose sign and magnitude are a function of
the pathway stoichiometry, the elasticities, and the ratios of ﬂuxes
in branched pathways. In systems with moiety conservations,
concentrations are also required [8,10]. The sign of a control
coefﬁcient—positive or negative—is sufﬁcient to predict whether a
ﬂux or concentration will increase or decrease when an enzyme
activity is changed. Positive control coefﬁcient indicates that changes
in xg or Jqwill follow the same pattern as changes in vk. This means an
increase of vk will induce an increase of xg or Jq, while decreasing vk
will also decrease the value of xg or Jq.Negative control coefﬁcient, on
the contrary, indicates that changes in vkwill induce an inverse effect
on the changes in xg or Jq.
Some control coefﬁcients have ﬁxed signs, irrespective of the
magnitudes of the elasticities and ﬂuxes, and then they are either
always positive or always negative [13,14]. Other control coefﬁcients are
sign-indeterminate, meaning they can be positive or negative, and
some control coefﬁcients are always zero. The classiﬁcation into these
types of control coefﬁcients requires the only knowledge of the
metabolic network structure and the direction of regulatory depen-
dencies of the network,which basically refers to the positive or negative
sign of the elasticities: i) elasticities with respect to substrates or
activators are always positive; ii) elasticities with respect to inhibitors—
or products in reversible reactions—are always negative. The ﬁxed sign
will be maintained while both structure and qualitative regulatory
dependencies are maintained. Each control coefﬁcient predicts changes
in ﬂuxes and concentrations resulting from the change of one enzyme
activity. In general, the predictive value of this normalized derivative is
accurate for inﬁnitesimal changes of the enzyme activity and decays for
larger changes due to the redistribution of the elasticities and ﬂuxes. The
prediction of the sign of a sign-ﬁxed control coefﬁcient is a positive or
negative direction that is not modiﬁed for large changes.
In the present work, we take advantage of sign-ﬁxed control
coefﬁcients to derive hypotheses about the enzyme activities
which are modiﬁed in order to achieve speciﬁc changes in glycolytic
and pentose phosphate pathway (PPP) ﬂuxes and concentrations. As a
case study of metabolic reprogramming, we have analyzed the
transformation with mutated K-ras oncogenes of a mouse embryonic
ﬁbroblast cell line NIH-3T3. Oncogenic Ras-transformed NIH-3T3 cells
have been used as a model system to explore characteristics associatedwith cell transformation, such as a higher aerobic glycolysis and
changes of enzyme activities [15–18]. Ras proteins are a family of small
GTPases activated in response to extracellular stimuli and leading to the
activation of several signalling cascades [19–21]. Among the different
isoforms, K-Ras is the Ras protein which plays a major role in cancer.
NIH-3T3 cells stably transfected with constitutively active K-ras
mutated at codon 12 or codon 13 (K12- and K13-transformed
cells) induce tumours with distinct survival strategies, associated
with distinct transforming capabilities and aggressiveness [22,23].
Previously, we measured signiﬁcant changes in carbon metabolism
of K12- and K13-transformed cells based on stable-isotope (13C)
tracer-based technologies [24]. Interestingly, both mutants showed an
increased utilization of the oxidative branch of the PPP, higher for
K13 cells, compared with non-transformed NIH-3T3 cells.
In order to derive hypotheses about the enzyme activities that
contribute to the reprogramming of carbon metabolism: 1) we
characterized metabolic adaptations in non-transformed and K12-
and K13-transformed cells by means of experimentally measured
external and internal metabolite concentrations; and 2) we computed
the network ﬂux distribution using a constraint based approach and
the data obtained of external metabolite variations; 3) we identiﬁed
control coefﬁcients with ﬁxed signs in order to predict the pattern of
changes in enzyme activities which can explain the observed
increases or decreases in ﬂuxes and concentrations; and 4) ﬁnally,
wemeasured speciﬁc activities of key enzymes in order to validate the
predictions on the enzyme activity increases or decreases compatible
with the observed ﬂux and concentration changes.2. Materials and methods
A combination of experimental and mathematical–computational
methods was applied including the measurement of glucose uptake
(JA), lactate production (JT), and glutamate–glutamine uptake (JU)
together with measurements of sugar phosphate concentrations and
enzyme speciﬁc activities. All measures were replicated in inde-
pendent experiments. Mathematical–computational methods were
performed using Mathematica [25].2.1. Cell lines and culture
NIH-3T3 cells were obtained from the American Type Cell Culture
(ATCC). The transfectants contained a K-rasminigene with a G:C→A:
Tmutation at the ﬁrst position of codon 12 (K12 cells) and a G:C→A:T
mutation at the second position of codon 13 (K13). All lines were
maintained in Dulbecco's Modiﬁed Eagle Medium (DMEM) in the
presence of 10% FBS, 25 mM D-glucose and 4 mM L-glutamine, at 37 °C
in 95% air–5% CO2. Geneticin© Selective Antibiotic (GIBCO) was used
as a selective antibiotic in K12 and K13 cells.
For biochemical and enzyme activity measurements, cells were
seeded in p100 dishes at different densities between 0.8·106 and
1.2·106cells/cm2. 24 h after seeding, incubation medium was
removed and cells were incubated for 72 h with DMEM containing
10% FBS, 25 mM D-glucose and 4 mML-glutamine. At the end of the
incubations, media for biochemical analysis were removed and frozen
at−20 °C until processing. Cells for sugar phosphates determination
were immediately frozen in liquid nitrogen and kept at −80 °C until
processing. Cells for activity measurements were washed with PBS
and scrapped in a lysis buffer as detailed below. Cell counting was
performed with a haemocytometer.2.2. Protein concentration
Protein concentration of cell extracts was determined using the
BCA Protein Assay (Pierce Biotechnology, Rockford, IL).
Fig. 1. Network scheme. Each arrow indicates a reversible or irreversible reaction step
catalyzed by an enzyme (or transporter) or one block of enzymes. Grey dashed lines
account for the regulatory circuits (inhibitions and activations).
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Glucose, lactate, glutamate, and glutamine concentrations were
determined from frozen medium samples as previously described [26–
28] using a Cobas Mira Plus chemistry analyzer (ABX). The rates of the
medium metabolites consumption/production—glucose consumption
( JA), lactate production ( JT) and glutamate from glutamine consumption
( JU)—are derived from the total measured consumptions/production of
metabolites and corrected according to the measured cell proliferation,
assuming exponential growth and constant consumption or production.
The rate of glutamate from glutamine consumption is derived from the
measured rates of glutamine consumption and glutamate accumulation.
All the values are expressed in micromol of metabolite consumed or
produced per milligram of protein and hour (μmol mg prot−1 h−1).
2.4. Sugar phosphates determination
Hexose, pentose and triose phosphates were determined in cell
monolayers frozen in liquid nitrogen using addition curve methods as
described [29]. The MRM (multiple reaction monitoring) transitions
were 339/97 for fructose-1,6-bisphosphate (F16BP), 259/97 for
glucose-6-phosphate (G6P) and fructose-6-phosphate (F6P) (hexose
phosphates) (HexP), 229/97 for ribose-5-phosphate (R5P) and
xylulose-5-phosphate (pentose-phosphates) (PenP), 169/97 for
glyceraldehyde-3-phosphate (GAP) and dihydroxyacetone phos-
phate (triose phosphates) (TrisP) and 167/79 for phosphoenol
pyruvate (PEP). Sugar phosphate concentrations are expressed as
nanomol per milligram of protein (nmol mg prot−1).
2.5. Enzyme activity determinations
Activities of the glycolytic enzymes hexokinase (HK), pyruvate
kinase (PK), and lactate dehydrogenase (LDH), and PPP enzymes
glucose-6-phosphate dehydrogenase (G6PD) and transketolase (TKT),
were determined from cell culture extracts. Enzyme activities are
expressed as milliunits per milligram of protein (mUmg prot−1).
Preparationof cell extracts for enzymeactivity determination. Cell cultures
were washed with PBS and scrapped in lysis buffer (20mM Tris–HCl, pH
7.5, 1 mM dithiothreitol, 1 mM EDTA, 0.02% Triton X-100, 0.02% sodium
deoxycholate) supplemented with protease and phosphatase inhibition
cocktails. Cell lysates were disrupted by sonication (3 cycles of 5 s) and
immediatelyultracentrifugedat105,000 ×g for1 hat4 °C. Thesupernatant
was separated and used for the determination of enzyme activities using a
CobasMiraPlus chemistry analyzer (HORIBAABX,Montpellier, France). All
enzymatic activities were determined by monitoring NADH/NADPH
increment or decrement at a wavelength of 340 nm.
A strong decrease of the mitochondrial Complex I activity has been
recently reported inK-ras transformed cells [30]. The conditions of extract
preparation using a soft lysis buffer as well as soft sonication have been
optimised tominimise the extraction of mitochondrial Complex I activity
and other membrane-bound enzymes. The absence of unspeciﬁc
coenzyme (NADHorNADPH) consumption/production has been checked
before the addition of the reaction substrate for all the enzyme activities
measured.
Glucose-6-phosphate dehydrogenase (G6PD, EC 1.1.1.49) activity
was measured as described in Tian et al. [31]. Brieﬂy, samples were
added to a cuvette containing 0.5 mM NADP+ in 50 mM Tris–HCl, pH
7.6 at 37 °C. Reactions were initiated by the addition of G6P up to a
ﬁnal concentration of 2 mM.
Hexokinase (HK, EC 2.7.1.1) activity was determined by coupling
HK reaction to G6PD enzyme in the following conditions: 3.3 mM
NADP+, 14.8 mM ATP, 14.8 mM MgCl2, 2.8 U/mL G6PD and 50 mM
Tris–HCl, pH 7.6 at 37 °C. Reactions were initiated by the addition of
glucose to a ﬁnal concentration of 10 mM.
Transketolase (TKT, EC 2.2.1.1) activity was determined using the
enzyme linked method described by Smeets and colleagues [32]. Brieﬂy,samples were added to a cuvette containing 5 mMMgCl2, 0.2 U/ml triose
phosphate isomerase, 0.2 mMNADH, 0.1 mM thiamine pyrophosphate in
50 mM Tris–HCl, and pH 7.6 at 37 °C. The reaction was initiated by the
addition of a substratemixture in 1:2 proportion (substratemixture :ﬁnal
volume) prepared by dissolving 50 mM R5P in 50 mM Tris–HCl, pH 7.6
with 0.1 U/ml ribulose-5-phosphate-3-epimerase and 1.7 mU/ml phos-
phoriboisomerase. The substrate mixture was continuously stirred and
heated for 1 h at 37 °C and then kept at−20 °C until use.
Pyruvate kinase (PK, EC 2.7.1.40) activity was determined by coupling
the PK reaction to the LDH enzyme in the following conditions: 0.8 mM
NADH, 1.6 mM ADP, 12.1 mM MgCl2, 36.8 mM KCl, 5.2 U/mL LDH in
20 mM phosphate buffer, pH 7.2 at 37 °C. Reactions were initiated by the
addition of PEP up to a ﬁnal concentration of 3.5 mM.
LactateDehydrogenase (LDH, EC1.1.1.27) activitywasmeasuredat 37 °C
by adding sample extracts to a cuvette containing 0.2 mM of NADH and
100mMphosphatebuffer, pH7.4. Reactionwas initiatedby the additionof
pyruvate (Pyr) up to a ﬁnal concentration of 0.2 mM.2.6. Isotopomer abundances
13C labelled substrates generate for eachmetabolic product a set of
different labelled molecules—isotopomers—that differ only in the
labelling state of their individual carbon atoms. In a previous paper
[24] 50% [1,2-13C]-D-glucose was used as tracer and the generation of
13C labeled products was measured retaining for each product the
relative abundances of the non-labelled isotopomer form (m0), and
Fig. 2. Comparison of ﬂuxes. Non-transformed NIH-3T3 cells (white); K12-transformed
cells (light gray); and K13-transformed cells (dark gray). ▲) Increased ﬂux in
transformed cells with respect to non-transformed cells; and ▼) Decreased ﬂux in
transformed cells with respect to non-transformed cells. Some dependent ﬂuxes are
grouped together: JC and JE (JC,E); JF and JK (JF,K); JG, JH and JI (JG,H,I) ; JL, JM and JN (JL,M,N);
and JO and JP (JO,P).
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The isotopomer abundances of lactate are here applied to describe the
ratio of ﬂuxes through oxidative PPP (JB) with respect to the entry of
glucose ( JA) [33]: f1=JB/JA=3×(m1/m2)/(3+(m1/m2)).
2.7. Statistical analysis
Two-tailed Student's t-test was performed in order to compare
metabolite concentrations and activities of non-transfected against K12-
and K13-transfected cells. Differences were considered signiﬁcant for
pb0.1.
3. Results
3.1. Metabolic adaptations in K12- and K13-transformed NIH-3T3 cells
3.1.1. System description
The scheme of the whole network under study is depicted in Fig. 1.
Fluxes are represented with letter J, where Ji refers to the steady state
metabolic ﬂux through the ith step; concentrations are represented with
letter x, where xi refers to the concentration of the ith metabolic
intermediary; and activities are represented with letter v, where vi refers
to the rate of the isolated reaction of the ith step. Solid arrows (Fig. 1)—
reaction steps A to Z—refer to the principal carbonmetabolism, including
glycolysis, the PPP, the tricarboxylic acid cycle and the main inputs and
outputs. Some reactions were neglected and grouped into blocks—e.g.
reaction step F refers to the block from glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) to enolase—and others were assumed to be
involved in rapid equilibriums—e.g. glucose-6-phosphate isomerase.
Metabolites were combined into different pools: the pool x1 for HexP
refers to G6P and F6P; the pool x2 for PenP refers to R5P; ribulose-5-
phosphate and xylulose-5-phosphate; the pool x4 for TrisP refers to
dihydroxyacetone-phosphate (DHAP) and GAP; and the pool x13 refers to
oxaloacetate (Oaa) andmalate (Mal). The rest ofmetabolic intermediaries
are F16BP (x3), sedoheptulose-7-phosphate (x6; S7P), erythrose-4-
phosphate (x5; E4P), PEP (x7), Pyr (x8), acetyl-CoA (x9; ACoA), citrate
(x10; Cit),α-ketoglutarate (x11;αKG) and succinate-CoA (x12; SucCoA). In
our system, the main ﬂuxes in or out of the deﬁned metabolic network
correspond to experimentally measured glucose consumption ( JA),
glutamate from glutamine consumption ( JU), and lactate production
( JT). Additional output exchanges connected to biosynthetic processes
were not associated with a measured value ( JD, JX, JY, JZ).
3.1.2. Flux distributions
Under steady-state conditions, the ﬂux balance associatedwith the
stoichiometry constrains the dependences among ﬂuxes [34–36]. In
order to estimate the different ﬂux distributions of non-transformed,
K12- and K13-transformed cells, the ﬂuxes for internal reactions can
be expressed as dependent on a subset of ﬂuxes including all output
and input ﬂuxes, e.g.:
JC = JE = JA–
1
=3 JB + 2 × JDð Þ;
JF = JK = 2 × JA–
1
=3 JB + 5 × JDð Þ;
JGf =
1
=3 JB–JDð Þ + JGb;
JHf =
1
=3 JB–JDð Þ + JHb;
JIf =
1
=3 JB–JDð Þ + JIb;
JL = JM = 2 × JA–
1
=3 JB + 5 × JDð Þ–JT + JU–JX–JY–JZ ;
JN = 2 × JA–
1
=3 JB + 5 × JDð Þ–JT + JU–JX–2 × JY–JZ ;
JO = JP = 2 × JA–
1
=3 JB + 5 × JDð Þ–JT + 2 × JU–JX–2 × JY–JZ ;
JR = JU–JY–JZ ;
ð4Þwhere JGf, JHf, JIf and JGb, JHb, JIb are the forward (Jif) and backward (Jib)
ﬂuxes through the reversible reactions JG= JGf− JGb, JH= JHf− JHb,
and JI= JIf− JIb. An additional constraint was imposed based in our
previous isotopomer-based analysis of non-transformed NIH-3T3
cells and K12- and K13-transformed cells [24] (see Section 2.6):
JB = f1 × JA ð5Þ
where factor f1 relates the oxidative branch of PPP (JB) with the
entry of glucose (JA). This factor was set according to the measured
ratios [24]: 0.063±0.004 for non-transformed cells; 0.076±0.012
for K12-transformed cells; and 0.153±0.016 for K13-transformed
cells. Thus, the ﬂux through the oxidative branch of PPP was
signiﬁcantly lower than that descending through the glycolysis, and
there was a signiﬁcant increase of the ﬂux through the PPP in
transformed cells compared to non-transformed NIH-3T3 cells.
Between transformed cells, K13 mutants routed more glucose to
the oxidative branch of PPP than K12 mutants.
All these assumptions and measures are constraints limiting the
space of solutions for the internal metabolic ﬂuxes. Unfortunately, the
complete system cannot be determined with the available measure-
ments. Uncertainty is associated with the measured exchange ﬂuxes
( JA, JT, JU) and, specially, with those not measured ( JX, JY, JZ, JD). An
interval constraint satisfaction approach was applied as suggested by
Llaneras and Picó [37] for cases where available measurements are
insufﬁcient and the complete ﬂux distribution cannot be uniquely
calculated. The feasible range of solutions satisfying all constraints
was estimated for each reaction step. Initial lower and upper bounds
for intervals were assigned to the ﬂux through all reaction steps: 1)
lower and upper bounds were assigned as the mean value±
1.5×standard deviation for measured ﬂuxes JA, JT, and JU,; 2) a lower
bound of zero was assumed for the irreversible ﬂuxes JB, JD, JK, JL, JM, JN,
JO, JR, JS, JX, JY, JZ, which were assumed to have positive values (0b Ji).
For each cell type, the lower and upper bounds were constrained to
satisfy the stoichiometric description of the system Eq. (4) and the
isotopomer-based constraint in Eq. (5). These intervals of ﬂuxes
satisfying all constraints were calculated by two independent
procedures: 1) iterative interval propagation, or 2) solving each
minimum and maximum bound through linear programming, taking
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distributions for non-transformed cells, K12- and K13-transformed
cells are shown in Fig. 2, which graphically depicts the interval
ranges of ﬂux values which satisfy all the constraints. As an example,
for non-transformed cells, the initial intervals were 2.04b JAb3.41,
0b JBb∞, −∞b JCb∞, 0b JDb∞, −∞b JEb∞, −∞b JFb∞, 0b JGb∞, …,
6.63b JTb9.56, 0.20b JUb0.84,…, and the ﬁnal intervals satisfying all
constraints (solution space) computed with both iterative interval
propagation and linear programming were 2.93 b JA b3.41,
0 .18 b J B b0 .21 , 2 .86 b J C b3.34 , 0 b J D b0.57 , 2 .86 b J E b3.34 ,
5.80b JFb6.75, −0.11b JGb0.07, …, 6.63b JTb7.59, 0.20b JUb0.84, ….
Even with the propagated uncertainty, substantial changes in ﬂux
distribution are detected in transformed cells with respect non-
transformed cells, in particular for the ﬂux pattern in glycolysis and
the oxidative branch of the PPP.
3.1.3. Metabolite concentrations
Changes in ﬂuxes were coupled with additional experimental
measurement of key sugar phosphate concentrations. Thus, the
concentrations of HexP (x1), PenP (x2), F16BP (x3), TrisP (x4), and
PEP (x7) were measured for non-transformed and transformed cells
(K12 and K13) and are compared in Fig. 3. All concentrations were
found to be slightly decreased in transformed cells.
3.2. Predicted changes in ﬂuxes and concentrations
3.2.1. The sign of control coefﬁcients
In order to identify control coefﬁcients with ﬁxed signs, all regulatory
dependences were considered. The matrix approach proposed by
Cascante et al. [9,10] was applied and is depicted in Fig. 4. A matrixM−1
withall concentration control coefﬁcients andall independentﬂuxcontrol
coefﬁcients can be derived from the inverse of a matrixM containing all
elasticities and ﬂux dependences. The sign of the elasticities is taken in
order to derive the sign of the control coefﬁcients. For example, the
dependence of G6PD (reaction step B) on its substrate (HexP, x1)
corresponds to a positive elasticity εB1. In Fig. 1, grey dashed lines account
for the regulatory circuits—i.e. product (G6P, x1) inhibition ofHK (reaction
step A) [38], inhibition of phosphofructokinase (PFK, reaction step C) by
Cit (x10) [39] and activation of PK (reaction step K) by F16BP (x3) [40,41],
whichareassociatedwithnegative (εA1), negative (εC10) andpositive (εK3)Fig. 3. Comparison of measured concentrations. Values for concentrations are
proportional to the bar height for each chemical specie and error bars correspond to
standard deviations. See legend of Fig. 2 for meaning of colours and triangles. As a
reference for sugar phosphate concentrations, [F16BP]=3.229 nmolmg prot−1, [HexP]=
1.799 nmol mg prot−1, [PenP]=0.726 nmolmg prot−1, [TrisP]=2.710 nmolmg prot−1 and
[PEP]=0.457 nmolmg prot−1 for non-transformed NIH-3T3 cells. P-values using two-tailed
Student's t-test: *: pb0.1, **: pb0.05; ***: pb0.01.elasticities, respectively. Reversibility is associated with negative elastic-
ities with respect to products. Finally, reaction steps D, X, Y and Z
describing the demand of synthetic processes were assumed to be
saturated with respect to their respective substrates and then controlled
by thedemand; so, theelasticities εD2, εX8, εY10, and εZ13were set tobezero.
The sign of each control coefﬁcient was analyzed by checking the
positivity or negativity of the determinant |M| and the adjoint
matrices in Adj(M) used for the derivation of the inverse:
M−1 =
1
Mj j Adj Mð Þð Þ
T ð6Þ
Since the determinant |M| was positive, the sign depended on the
adjointmatrices. ThematrixM−1 in Fig. 4b shows all control coefﬁcients
for independent ﬂuxes and concentrations derived from this analysis.
Control coefﬁcients for the dependent ﬂuxes can be derived by
considering the dependences among ﬂuxes in Eq. (4) and the control
coefﬁcients of independent ﬂuxes [9,10], as demonstrated in the
example provided in Fig. 4c. A subset of control coefﬁcients signs are
presented in Fig. 4d in a table of dependences between the ﬂuxes and
concentrations and the main enzyme activities. Positive and negative
symbols correspond to control coefﬁcients with positive and negative
signs, respectively. The signs in Fig. 4d collectively give a complete
systemic predictive tool which can be used to evaluate the expected
impact of changes in enzyme activities. Thus, the speciﬁc pattern of
observed changes in ﬂuxes and concentrations can be associated with
increases or decreases of enzyme activities through analysis of the signs
of control coefﬁcients. For example, the observed decrease in the
concentration of PEP (x7) could correspond to an increase of PK activity
(vK), but never due to a decrease.
3.2.2. The magnitude of the control coefﬁcients
The analysis of the signs of metabolic control coefﬁcients is
sufﬁcient if the aim is to predict the direction of changes in
concentrations and ﬂuxes. However, this previous analysis does not
sufﬁce if the objectives are to predict the magnitudes of these
changes, and then the magnitude of the control coefﬁcients is
required. Unknown elasticities can be randomly sampled in order
to derive feasible magnitudes for control coefﬁcients [42]. We have
applied sampling procedures based on those described by Wang et
al. [42] in order to have an additional independent evaluation of
the sign and mean magnitude of the control coefﬁcients (results
exactly match the computed signs). This analysis identiﬁed a
subset of control coefﬁcients which are always associated with
small magnitudes. In the system considered (Fig. 1) the PPP is a
sub-network characterized by a ﬂux which is much smaller than
the main ﬂuxes through the rest of the network ( JB⋘ JC). The
effect of changes in the activity throughout this sub-network will
have minimal effect on the rest of the system, but these changes
can have a signiﬁcant effect on the concentrations and reaction
steps inside the sub-network. The dependence of control coefﬁ-
cients on particular ﬂuxes, such as JB, can be easily identiﬁed by
inspecting the adjoint matrices. Control coefﬁcients identiﬁed with
black circles in Fig. 4d are directly proportional to the value of JB,
which implies very small magnitudes due to the small ﬂux through
the oxidative branch of the PPP.
3.3. Testing and validation of hypotheses based on variations in enzyme
activities
3.3.1. Speciﬁc activities
The speciﬁc activities of HK (vA), G6PD (vB), TKT (vG, vH), PK (vK), and
LDH(vT)weremeasured fornon-transformedandtransformed(K12and
K13) cells and compared in Fig. 5a. Increases or decreases in speciﬁc
activities observed during the metabolic adaptation associated with the
K-ras transformation were analysed. Clear changes were observed for
Fig. 4.Matrix estimation of the sign of control coefﬁcients. For details about themethod see [9,10]. Elasticities with a magnitude of zero appear as 0, while those positives are represented
with a letter α (αki=εkiN0), and those negatives with a letter β (βki=εkib0); control coefﬁcients with a magnitude of zero appear as 0, while these positives are represented with the
letterA (Aki=CkiN0) or a symbol "+", and these negativeswith the letter B (Bki=Ckib0) or a symbol "−"; Those control coefﬁcients with indeterminate signs are representedwith a letter
G (Gki=CkiN0 or Ckib0) or a symbol "±". A matrix M (a) with the information containing both the stoichiometry and the regulatory properties of the analysed system (elasticities and
ratios among ﬂuxes), is inverted to obtain the matrix of control coefﬁcientsM−1 (b) for independent ﬂuxes and concentrations. (c) An example of estimation of a control coefﬁcient of
dependent ﬂuxes from the previously estimated control coefﬁcients of independent ﬂuxes. (d) Table of dependences connecting changes in ﬂuxes and concentrations with changes in
enzyme activities for a subset of analyzed control coefﬁcients. Superscripts "f" and "b" refers to net direction of reversible reactions of the non-oxidative branch of PPP (G,H,I) following the
forward or the backward directions, respectively. The net ﬂuxes for the remaining reversible reactions are set to follow only the forward direction according to Fig. 2. Symbols
("+","−","±") identiﬁed with a black circle refer to control coefﬁcients of very low magnitude in comparison with the other ones (see Section 3.2.2).
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changesalsoforTKTwithbothK12andK13transformedcellsandalsofor
PKwith K13 transformed cells. There were no signiﬁcant changes in the
observed HK activities.3.3.2. Do changes in measured activities satisfy the predictions for
concentrations and ﬂuxes?
The table of dependences in Fig. 5b identiﬁes both satisﬁed and
non-satisﬁed predictions of the sign of control coefﬁcients for those
752 P. de Atauri et al. / Biochimica et Biophysica Acta 1807 (2011) 746–754activities with measured changes (vB, vG, vH, vK and vT). Satisﬁed
predictions, which are those where the direction of the changes in a
concentration or ﬂux is explained by the direction of the change in an
enzyme activity, are marked in green. Otherwise, if the prediction is
not satisﬁed, the sign of the control coefﬁcients is marked in red. For
example, the increase in LDH activity (vT) could help to explain the
measured increase in JA, but not the increase in JB, which is satisﬁed by
the increased G6PD activity (vB). Predictions regarding TKT are more
complicated because the slight decrease of TKT activity could
contribute to a predicted decrease of PenP levels (x2), but only if the
net ﬂux through the non-oxidative branch of PPP is following the
backward direction to PenP as is shown in Fig. 5b.
Indeterminate signs (±) identify control coefﬁcients that can be
positive or negative, depending on the relative values of the
elasticities and ratios between ﬂuxes. For a set of such sign-
indeterminate control coefﬁcients, only a limited combination of
positive and negative signs is possible. Indeterminate signs (±)
marked in green were used in Fig. 5b to highlight that a speciﬁc and
feasible combination of elasticities and ﬂuxes can result in a
combination of signs which satisfy the changes in ﬂuxes andFig. 5. Speciﬁc activities and satisﬁed predictions. (a) Comparison of speciﬁc activities.
See legend of Figs. 2 and 3 formeaning of bar height, error bars, colours and triangles. As
a reference for speciﬁc activities, HK=130.17 mU mg prot−1, LDH=2.83 Umg prot−1,
G6PD=215.02 mU mg prot−1, TKT=35.72 mU mg prot−1 and PK=6.98 Umg prot−1
for non-transformed NIH-3T3 cells. P-values using two-tailed Student's t-test: *: pb0.1,
**: pb0.05; ***: pb0.01. (b) Satisﬁed predictions represented in the table of
dependences connecting changes in ﬂuxes and concentrations with changes in enzyme
activities. See legend of Fig. 4 for meaning of superscripts "f" and "b", and positive-
negative symbols ("+","−","±"). Symbols marked in green or red refers to control
coefﬁcients that can explain or cannot explain, respectively, the observed directions of a
change in a ﬂux or a concentration with respect to the direction of ameasured change in
an enzyme activity (see Section 3.3.2).concentrations. For example, the measured decreases in x2, x4, and
x7 can be predicted by an increase in vT activity, which is possible
because the negative control coefﬁcients for C2T, C4T, and C7T can be
obtained by selecting the appropriate elasticities.4. Discussion
The existence of control coefﬁcients with ﬁxed or indeterminate
signs is dependent on the topology of the metabolic pathway and
location of regulatory loops (feedback, feed-forward), branches, etc.
[13]. The signs of the control coefﬁcients estimated above (Fig. 4)
were obtained by assuming a model adapted to the available data,
where the relevant topology and regulation are considered. Analysis
of the signs of control coefﬁcients in Fig. 5b provides a complete
picture of the potential effect that any change in enzyme activities
would have on systemic properties such as ﬂuxes and metabolite
concentrations. This picture conﬁrms that the increased ﬂuxes from
glucose to lactate ( JA, JC, JE, JF, JK, JT) and through the oxidative part of
the PPP (JB) (Fig. 2), and the decreased concentrations of sugar
phosphates (x1, x2, x3, x4, x7) (Fig. 3), observed in transformed cells,
can be explained in part by the increased speciﬁc activities for G6PD
(vB), PK (vK), LDH (vT), and decreased activity of TKT (vG,vH) (Fig. 5a).
Interestingly, the differences between the phenotypes of K12 and K13
tranformed cells [22–24] are reﬂected by the magnitude of the
changes in ﬂuxes and not by the sign of these changes. Changes in
enzyme activities are also in the same direction (with the same sign of
change) for both transformed cells with the exception of PK activity
which is only increased signiﬁcantly in the K13 cell line.
The measured changes in speciﬁc enzyme activities accounts for
changes in the enzyme concentrations. It should be noted that in vivo,
changes affecting an enzyme activity can be as a result of the changes
on its expression but also due to a variety of events including: changes
in cofactors, post-transductional modiﬁcation or changes in oligo-
merization state among others. One example of this is the case of PK.
Among the different PK isoforms, the M2-PK isoenzyme is expressed
in all proliferating cells, including embryonic, tumour and NIH-3T3
cells [41]. The M2-PK isoenzyme occurs in a highly active tetrameric
form and in a dimeric formwith low afﬁnity for PEP [40]. The tetramer
to dimer ratio of M2-PK is not static and depends on F16BP levels in
addition to any effects due to other external mechanisms [40].
The measured changes of the speciﬁc activities for G6PD (vB), PK
(vK), and LDH (vT) satisfy the predictions based on the sign of the
control coefﬁcients. Interestingly, Fig. 5b shows that the set of
observed changes in ﬂuxes and concentrations accompanying K12-
and K13-transformation cannot be attributed to the perturbation of a
single enzyme activity. According to results depicted in Fig. 5b,
simultaneous activation of G6PD and some of the glycolytic enzymes
is required in order to fully explain the observed pattern of changes in
ﬂuxes and metabolite concentrations. The experimentally measured
increase in G6PD and in some glycolytic enzymes (LDH (vT) and PK
(vK)) conﬁrms this prediction and helps to explain qualitatively
almost all observed increases in ﬂuxes and decreases in concentra-
tions, although it is likely that other glycolytic enzyme activities could
also be increased. The predictions of Fig. 5b are also in agreement with
the available literature on tumour metabolism that suggests the
action of transcription factors, as c-myc and the hypoxia-inducible
transcription factor 1 (HIF-1), which are associated with the
activation of oncogenes including transforming ras. This leads to the
reprogramming of different components of the cell metabolism,
including higher expression for most of the genes encoding
glycolytic enzymes [38,43–48]. Among the enhanced enzymes are
mammalian isoforms of HK (HK1 and 2), PK (M2-PK) and LDH
(LDH-A). We have also observed changes in LDH for both K12 and
K13 cells in addition to changes in PK for K13 cells. However, HK
activity is not signiﬁcantly altered by either of the two transformed cell
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the same K12- and K13-transformed NIH-3T3 cells used in the present
study, they showed an increased expression of GAPDH for both
transformed cell lineswith respect to the non-transformed ones. From
Fig. 5b we can predict that this increase of GAPDH (vF) can also
contribute to the observed metabolic phenotype of transformed cells.
Taking into account that control is distributed among the enzymes
of glycolysis, it is not surprising that simultaneously increasing a
number of different glycolytic enzymes is required in order to achieve
a large increase in glycolytic ﬂux. Thus, in a linear pathway, all the
control coefﬁcients are positive and their sum is equal to one [3],
which means that, if the control is shared between several enzymes,
then the magnitude of each individual control coefﬁcient is expected
to be quite low. A very low control coefﬁcient indicates that in order to
alter the ﬂux signiﬁcantly by using modiﬁcations of a single enzyme, a
very large change in the enzyme concentration is required. However,
a simultaneously balanced change in all glycolytic enzyme concentra-
tions should result in both a directly proportional change in the
glycolytic ﬂux and also the absence of change in intermediate
metabolites [49]. The observed slight decrease in all measured
metabolites could be the consequence of increased external demands.
However, it is also interesting to notice that according to Fig. 5b
the observed increase in the ﬂux through the oxidative part of PPP is
not predicted by an increase in measured glycolytic activities, but is
clearly satisﬁed by an increase in G6PD activity. Comparing K12 and
K13 cells, there is a perfect agreement between the higher G6PD
activity and the higher ﬂux through the oxidative part of the PPP.
Regulation of the expression of G6PD is altered in many tumours,
resulting in a signiﬁcant increase in G6PD activity, and it has been
suggested that G6PD may act as a potential oncogene [50]. Increased
G6PD activity in NIH-3T3 cells, transfected with human G6PD cDNA,
leads to tumorogenic transformations, dividing more quickly and
inducing tumors in nude mice [50]. The decreased levels of PenP (x2)
are not compatible with the increased activity of G6PD, but are
compatible with an increased demand of ribose (reaction step D).
Also, the decreased levels of PenP can be at least in part a
consequence of the slight decrease in the TKT activity. The two key
enzymes of the PPP, G6PD and TKT, were both previously identiﬁed
as potential targets in cancer therapy [51–54], and recently, the
increased G6PD/TKT ratio was proposed as a tumour metabolome
feature [55]. The observed notorious increase of G6PD resulted in a
higher G6PD/TKT ratio in both transformed cell lines with respect to
non-transformed cells in agreement with the results of Montoya et
al. [55]. Here, we have also found that this ratio is higher in K13 than
in K12.
Finally, it is interesting to note the fact that metabolic adaptations
observed in transformed cells require changes in more than one
enzyme, which suggests that a multi-hit strategywould be required to
counteract metabolic adaptations in transformed cells. These results
support the suggestions of Moreno-Sanchez et al. [56] who proposed
that a "multi-targeted MCA advised therapy" would be required to
design efﬁcient treatments in cancer based on the fact that control is
shared among several steps in metabolic networks.
5. Conclusion
An interesting advantage of control coefﬁcients with ﬁxed signs is
that they confer robustness to the system [14]. Consistently,
predictions based on ﬁxed signs of control coefﬁcients are also very
robust. The structure of the metabolic network and the regulatory
dependences affecting most of the metabolic processes, speciﬁcally
those associated with the carbon metabolism, are available and
sufﬁcient to predict the sign ofmetabolic control coefﬁcients.We have
proposed and veriﬁed the use of ﬁxed signs of metabolic control
coefﬁcients as a useful tool to evaluate the key enzyme activities
underlying metabolic adaptations associated with K-ras oncogenictransformation in NIH-3T3 cells. The predicted changes of G6PD, TKT,
PK, and LDH activities give very good agreement with the observed
pattern of changes in ﬂuxes and concentrations. Thus, with a limited
knowledge of themetabolic network structure and regulatory circuits,
the proposed analysis arises as a tool which can provide a complete
picture of predictable effects based on systemic properties—changes
in ﬂuxes and metabolite concentrations—with respect to changes in
enzyme activities.
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